Researchers have figured out how regular alcohol use impairs the effectiveness of a popular form of cancer immunotherapy, according to their analysis of mouse models and data from a patient cohort. Their discoveries are some of the first to establish how alcohol disrupts anti-cancer immunity at the molecular level, and also point to several therapeutic approaches to restore the effectiveness of immunotherapy. Studies have shown that alcohol consumption can weaken the immune system's ability to fight off viruses, bacteria, and tumor cells. Although clinicians often caution patients with cancer to avoid alcohol consumption, recent studies have shown that as many as 76.4% of patients still drink alcohol. Therefore, medical societies have called for more research to investigate how alcohol impacts treatment outcomes in patients. Here, Kristen Gilley and colleagues examined the impact of alcohol consumption in mouse models of lung and bladder cancer. They gave the mice a moderate-to-heavy amount of ethanol – equivalent to three to six drinks a day in a person – while administering anti-PD-1 antibodies, a form of immune checkpoint inhibition. The alcohol reduced the effectiveness of the treatment by roughly 50% and raised the risk of tumor relapse, primarily by suppressing tumor-infiltrating and memory T cells while boosting other T cells that carry an immune-suppressing receptor named TIGIT. However, targeting TIGIT with antibodies restored the efficacy of anti-PD-1 antibodies in the rodents. Gilley et al. then retrospectively studied a cohort of patients with skin, lung, bladder, or head and neck cancer, and found that people who self-reported having eight or more drinks a week had poorer survival rates after starting immune checkpoint inhibition. "This work is an initial resource toward establishing the risk of regular alcohol use on the efficacy of [immune checkpoint inhibition] and identifying the mechanisms that might be targeted for intervention," Gilley et al. write, adding that incorporating patient's alcohol use into cancer databases could shed light on its effect on other types of cancer therapies.
Research May Explain How Alcohol Weakens Cancer Immunotherapy
American Association for the Advancement of Science (AAAS)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.